With a cult of cost-chainsawing threatening every facet of the US government, what might become of the tens of thousands of ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer, today announced that an ...

MidJourney: A creative AI tool known for generating amazing and innovative visuals based on user prompts. MidJourney is ...

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies in 2025 for the treatment of small cell lung cancer Firs ...

Clinigen, the global speciality pharmaceutical services group, today announced that Equity Pharmaceuticals, part of the Clinigen Group, has entered into a new collaboration with Servier, an ...

Saving the best till last - a hackneyed phrase, and a song to boot - but one which perfectly summed up our stay at The ...

St. Paul has put a hefty price tag on its long-awaited plan to reinvent a crucial swath of downtown, including the Minnesota ...

Jiakun’s portfolio is expansive ... “Architecture should reveal something—it should abstract, distill and make visible the inherent qualities of local people. It has the power to shape ...